Functional Genomics Industry Insights: Market Forecast to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Functional Genomics Market Expected To Become By 2029 Compared With Its 2025 Level?
The functional genomics market has seen rapid expansion in recent years. Its value is expected to increase from $12.96 billion in 2024 to $14.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. This historical growth can be attributed to a heightened focus on gene expression studies, the rising application of functional assays in drug discovery, the emergence of more biotech firms, increasing advancements in high-throughput screening methods, and a greater integration of bioinformatics within genomics research.
The functional genomics market is projected to experience substantial expansion over the coming years, reaching $25.19 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.2%. This anticipated growth during the forecast period is primarily driven by several factors, including escalating investments in precision medicine, wider acceptance of multi-omics approaches, a heightened need for advanced genetic testing, the expanding utility of functional genomics in oncology, and increased funding for research and development initiatives. Key trends shaping the market within this period encompass progress in single-cell sequencing technologies, the creation of cloud-based genomic data platforms, breakthroughs in high-throughput functional screening methods, enhanced integration of genomics with proteomics, and the formulation of personalized therapeutic strategies utilizing functional genomics.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28228&type=smp
Which Major Market Drivers Are Shaping The Future Of The Functional Genomics Market?
Increased investment in research and development is anticipated to propel the expansion of the functional genomics market moving forward. Research and development refers to the structured effort to generate, improve, and innovate products, processes, or understanding through systematic investigation and experimentation. Funding in research and development is on the rise as businesses increasingly pursue innovation to remain competitive, prompting them to allocate greater resources towards developing novel products, enhancing technologies, and capturing emerging market opportunities. Investment in research and development benefits functional genomics by furthering the identification and analysis of gene functions, thereby improving our comprehension of complex biological processes and supporting the creation of precise therapeutic strategies. For instance, in December 2022, the Department of Health and Social Care, a UK-based government department, disclosed that the government announced an investment of £105 million to expedite the diagnosis of rare genetic conditions in newborns, with the aim of providing critical, potentially life-saving treatments for many infants. This funding will back research focused on advancing genomic healthcare by examining the DNA of patients. Therefore, the growing investment in research and development is driving the growth of the functional genomics market.
How Is The Functional Genomics Market Segmented?
The functional genomics market covered in this report is segmented as
1) By Product: Kits And Assays, Instruments
2) By Technology: Next-Generation Sequencing (NGS), Microarray Analysis, CRISPR And Gene Editing Technologies, RNA Sequencing (RNA-Seq)
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CROs), Clinical Laboratories, Agricultural Biotechnology Companies
Subsegments:
1) By Kits And Assays: PCR Kits, Microarray Kits, NGS Kits, Reagents, Enzymes
2) By Instruments: Sequencers, Microarray Scanners, PCR Instruments, Automation Systems
Which Competitive Trends Are Defining The Functional Genomics Market Structure?
Leading companies in the functional genomics market are prioritizing the development of sophisticated techniques, such as high-throughput sequencing, to offer remarkably accurate and comprehensive insights into complex genomes. High-throughput sequencing is a methodology that allows for the rapid and simultaneous sequencing of significant quantities of DNA or RNA, enabling broad-scale genetic information analysis. For example, in February 2025, Roche, a Switzerland-based pharmaceutical firm, introduced its sequencing by expansion (SBX) technology, thereby creating a new category within next-generation sequencing. This SBX chemistry, coupled with an advanced sensor module, facilitates ultra-fast, high-throughput sequencing that is both adaptable and scalable for various applications. This innovative approach converts the DNA or RNA sequence into a detectable surrogate polymer called an Xpandomer via a precise biochemical process. Xpandomers, which are fifty times longer than the original nucleic acid, translate sequence information into strong, low-noise signals for clear and dependable detection. By leveraging a CMOS-based sensor with parallel processing, this technique achieves highly accurate single-molecule nanopore sequencing, notable for its exceptional speed and versatility.
Who Are The Key Multinational Companies Dominating The Functional Genomics Market?
Major companies operating in the functional genomics market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Perkin Elmer Inc., Revvity Inc., Exact Sciences Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Integrated DNA Technologies Inc., Promega Corporation, Pacific Biosciences of California Inc., Genomics Ltd., MEDiC LLC, Enhanc3D Genomics Ltd., Samplix, Arima Genomics Inc., Phase Genomics Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/functional-genomics-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Functional Genomics Market?
North America was the largest region in the functional genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in functional genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Functional Genomics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28228&type=smp
Browse Through More Reports Similar to the Global Functional Genomics Market 2025, By The Business Research Company
Genomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-global-market-report
Metagenomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report
Genomics Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
